Nancy Ryan Gray
Director · LIGAND PHARMACEUTICALS INC
- 2025
- Jun 9, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Nancy Ryan Gray files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M in LGND purchases and sales in the last 12 months
- Andrew Reardon - $10.29M in LGND purchases and sales in the last 12 months
- Jason Haas - $3.74M in LGND purchases and sales in the last 12 months
- John L. Lamattina - $2.44M in LGND purchases and sales in the last 12 months
- Jason Aryeh - $1.25M in LGND purchases and sales in the last 12 months
- Stephen L. Sabba - $1.16M in LGND purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Nancy Ryan Gray?
Nancy Ryan Gray is a corporate insider, tracked as Director of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Nancy Ryan Gray last file a Form 4?
The most recent primary Form 4 on record is dated 9 June 2026, one of 2 filings going back to 2025.
Has Nancy Ryan Gray been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.35M) across all tracked filings.
